- Home
- ABEO vs CMCO Comparison
ABEO vs CMCO Comparison
Compare ABEO & CMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | CMCO |
|---|---|---|
| Founded | 1974 | 1875 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 417.1M |
| IPO Year | 2005 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ABEO | CMCO |
|---|---|---|
| Price | $6.35 | $19.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $20.00 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 1.2M | 739.7K |
| Earning Date | 05-13-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,998,000.00 | ★ $936,240,000.00 |
| Revenue This Year | $1,024.31 | $19.73 |
| Revenue Next Year | $145.42 | $82.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.18 | 3.27 |
| 52 Week Low | $4.00 | $11.99 |
| 52 Week High | $7.65 | $24.40 |
Technical Indicators
Market Signals| Indicator | ABEO | CMCO |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 57.77 |
| Support Level | $4.94 | $13.66 |
| Resistance Level | $7.36 | $19.80 |
| Average True Range (ATR) | 0.31 | 1.38 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 26.37 | 59.74 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About CMCO Columbus McKinnon Corporation
Columbus McKinnon Corp is a world'wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements.The Company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.